A Food and Drug Administration advisory panel met to discuss regulatory approval for the Alzheimer's drug, Leqembi.
Share:
More In Science
The U.S. Leads the World in Weather Catastrophes. Here's Why.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
32 Dead as Tornadoes Torment From Arkansas to Delaware
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
Good2Know: T-Rex Had Lips & Plants Can Talk
Good2Know is your daily dose of the stories that could impact your life.
Meatball Made From DNA of Woolly Mammoth
An Australian startup developed a meatball made from the DNA of the extinct woolly mammoth.
Narcan to Be Made Available Over-the-Counter
The Food and Drug Administration approved the sale of Narcan, the overdose antidote drug, as an over-the-counter medication.
FDA Approves Over-the-Counter Narcan. Here's What It Means
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Greenland Makes Daylight Saving Time Permanent
Greenland Makes Daylight Savings Time Permanent
Millions of Americans Could Lose Medicaid on April 1
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
Lack of Primary Care Providers Is Hurting Health Outcomes, Says Expert
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
